This inventor holds 3 USPTO granted patents and 1 published patent application and 1 EPO patent. Top assignee: Millennium Pharmaceuticals Limited. Active years: 2010-2011.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2010-2011
Title: The Innovative Contributions of Jeremy D Little
Introduction
Jeremy D Little is a notable inventor based in Wakefield, MA (US). He has made significant contributions to the field of pharmaceuticals, particularly in the treatment of inflammatory diseases. With a total of 3 patents to his name, his work has the potential to impact many lives.
Latest Patents
Among his latest patents, Jeremy has developed PGD2 receptor antagonists for the treatment of inflammatory diseases. This invention discloses CRTH2 inhibitors represented by Structural Formula (I), with specific values for the variables provided in the documentation. Additionally, he has created beta-carbolines useful for treating inflammatory diseases. This invention presents beta-carboline compounds of formula III-A-aa, which are effective in treating diseases such as inflammatory diseases and cancer.
Career Highlights
Jeremy D Little is currently associated with Millennium Pharmaceuticals Limited, where he continues to innovate and contribute to the pharmaceutical industry. His work focuses on developing new treatments that address pressing health issues.
Collaborations
Throughout his career, Jeremy has collaborated with talented individuals such as Michael E Hepperle and Julie Fields Liu. These partnerships have fostered a creative environment that enhances the development of innovative solutions.
Conclusion
In summary, Jeremy D Little is a dedicated inventor whose work in pharmaceuticals is paving the way for new treatments for inflammatory diseases. His contributions are significant and reflect his commitment to improving health outcomes.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile